دورية أكاديمية
أعرض في EDS

Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines

التفاصيل البيبلوغرافية
العنوان: Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines
المؤلفون: Luo, WenxinAff1, Aff2, Aff3, Aff4, Aff5, Gan, Jiadi, Luo, ZhuAff1, Aff6, Li, ShuangqingAff7, Aff8, Wang, ZhoufengAff2, Aff3, Aff4, Wu, Jiaxuan, Zhang, Huohuo, Xian, JinghongAff1, Aff2, Aff3, Aff4, Aff9, Cheng, Ruixin, Tang, XiumeiAff1, Aff10, Liu, Yi, Yang, Ling, Mou, QianqianAff6, Aff10, Zhang, XueAff6, Aff10, Chen, Yi, Wang, Weiwen, Wang, Yantong, Bai, Lin, Wei, Xuan, Zhang, Rui, Yang, LanAff1, Aff2, Aff3, Aff4, Chen, Yaxin, Yang, Li, Li, YalunAff1, Aff2, Aff3, Aff4, Liu, DanAff1, Aff2, Aff3, Aff4, Aff5, IDs41392024017511_cor25, Li, WeiminAff1, Aff2, Aff3, Aff4, Aff5, Aff9, IDs41392024017511_cor26, Chen, LeiAff14, IDs41392024017511_cor27
المصدر: Signal Transduction and Targeted Therapy. 9(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:20593635
DOI:10.1038/s41392-024-01751-1